Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 20 articles:
HTML format

Single Articles

    October 2019
  1. MEZA G, Exposito A, Royo JL, Ruiz-Garcia C, et al
    Association of CR2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 Vaccine.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002401.
    PubMed     Abstract available

  2. BARRY PA, Deere JD, Yue Y, Chang WW, et al
    Cytomegalovirus (CMV)-Vectored vaccines for HIV and other pathogens.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002396.

  3. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix): Erratum Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection: E
    AIDS. 2019;33:1957.

    August 2019
  4. FLYNN PM, Abrams EJ
    Response to correspondence entitled: Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1675-1677.

  5. DAUBY N
    Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1674-1675.

    July 2019
  6. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    PubMed     Abstract available

  7. DURIER C, Desaint C, Lelievre JD, Silbermann B, et al
    Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002310.
    PubMed     Abstract available

    March 2019

  8. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination: Erratum.
    AIDS. 2019;33:771.

  9. MACHIELS JD, Braam EE, van Bentum P, van Vugt M, et al
    Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate.
    AIDS. 2019;33:503-507.
    PubMed     Abstract available

  10. PANNUS P, Adams P, Willems E, Heyndrickx L, et al
    In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.
    AIDS. 2019;33:387-398.
    PubMed     Abstract available

    October 2018
  11. PALICH R, Ghosn J, Chaillon A, Boilet V, et al
    Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002058.
    PubMed     Abstract available

  12. LEAL L, Guardo AC, Moron-Lopez S, Salgado M, et al
    Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002026.
    PubMed     Abstract available

    September 2018
  13. LUO Z, Ogunrinde E, Li M, Zhang L, et al
    Increased influenza-specific antibody avidity in HIV-infected females compared to HIV-infected males on antiretroviral therapy.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002022.
    PubMed     Abstract available

    August 2018
  14. COLIN DE VERDIERE N, Durier C, Samri A, Meiffredy V, et al
    Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001963.
    PubMed     Abstract available

    May 2018
  15. WINCKELMANN A, Morcilla V, Shao W, Schleimann MH, et al
    Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001861.
    PubMed     Abstract available

    April 2018
  16. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
    Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
    PubMed     Abstract available

    March 2018
  17. ISMAIL MF, Wong DK, Bogoch II
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS. 2018;32:675-676.

    February 2018
  18. FARFOUR E, Lesprit P, Wai ACH, Mazaux L, et al
    Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage.
    AIDS. 2018;32:531-532.

  19. PALLIKKUTH S, De Armas LR, Pahwa R, Rinaldi S, et al
    Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001774.
    PubMed     Abstract available

  20. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
    Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.